"Manual Therapy Moves to Managed Care Reimbursement... Non-Life Insurers to Benefit in Second Half" [Click e-Stock]
Improvements Expected in Loss Ratio Gap
Hyundai Marine & Fire and DB Insurance Anticipated to Benefit Most
There are projections that with the conversion of manual therapy to managed care reimbursement, non-life insurance companies will see improvements in their loss ratio (the difference between expected and actual insurance payouts) in the second half of the year. In particular, it is expected that companies such as Hyundai Marine & Fire Insurance and DB Insurance, which have a high proportion of indemnity health insurance policies and high loss ratios, will benefit the most.
On June 15, Jeon Bae-seung, an analyst at LS Securities, stated, "The introduction of managed care reimbursement is positive for insurance company earnings, as it not only leads to a significant drop in payment rates but also simultaneously reduces the overall frequency and the number of excessive treatments." He further explained, "The benefit is expected to be even greater for second-tier insurers, such as Hyundai Marine & Fire Insurance and DB Insurance, which have a large share of indemnity health insurance and high loss ratios."
Manual therapy refers to treatments performed by doctors or physical therapists using their hands to treat musculoskeletal pain. Until now, it had been classified as a non-reimbursed service not covered by national health insurance. Prices varied significantly by medical institution, and while some therapeutic effects were recognized, its selective and supplementary nature led to persistent concerns about excessive and inappropriate treatments.
Managed care reimbursement is a system in which the government sets prices and treatment guidelines for non-reimbursed services that are at risk of being overused. The government introduced this system as part of the second phase of its healthcare reform plan, and established its legal basis in February this year by amending the National Health Insurance Act Enforcement Decree. Manual therapy is the first service to be included under this system.
The annual indemnity health insurance payout for musculoskeletal disorders, including manual therapy, amounts to 2.7 trillion won, accounting for 16% of all indemnity health insurance claims. Analyst Jeon explained, "Manual therapy is the largest single non-reimbursed item, with insurance payouts of approximately 1.5 trillion won," adding, "Due to ongoing concerns about misuse and overuse, it was chosen as a target for managed care reimbursement."
Currently, the total annual amount claimed for manual therapy by leading non-life insurers is around 150 billion won, with each session costing between 100,000 and 150,000 won. Analyst Jeon estimated that with inclusion in managed care reimbursement, the unit price could drop to as low as one-third of the current level, and the expected reduction in insurance payouts could reach 50 to 100 billion won per company.
There is analysis that the positive effects could be even greater. The new 5th-generation and 4th-generation indemnity health insurance policies (for those renewing from July this year) have a high co-payment rate of 95%, so the insurer's burden per manual therapy session is only 2,000 won.
Analyst Jeon commented, "As the payment rate falls, the supply of manual therapy services is also expected to decrease, which could amplify the positive effects," and added, "Since the impact of managed care reimbursement has not been reflected in each company's expected insurance payout calculations, an immediate improvement in the loss ratio is expected from the second half of the year."
However, there are concerns that preventing the so-called 'balloon effect' will be a key challenge. Analyst Jeon noted, "Since managed care reimbursement is essentially used as a tool to control the volume of medical services, if there is improvement in the misuse of manual therapy, the designation of managed care reimbursement could be expanded to other non-reimbursed items prone to excessive treatment."
In fact, non-reimbursed injections and extracorporeal shockwave therapy, which rank second and third in indemnity health insurance claim amounts, have not yet been included in managed care reimbursement. Insurance payouts for non-reimbursed injections increased by 32% last year. The fact that the inclusion of manual therapy in managed care reimbursement may incentivize medical institutions to increase their use of other non-reimbursed services is seen as a potential burden.
Hot Picks Today
"Two Spend 500,000 Won in a Flash, Yet Wait Two Hours?" ... 'Dreamland' Shunned by Kids and Foreign Tourists
- The Era of Getting 200 Million Won After 30 Years Is Over... A Japanese Bank's "Perpetual Department Head" Who Just Clocked In Cries Out
- Spain Hit by Its Worst Tragedy... Lee Kangin, Moreno and Real Madrid Join Soccer World in Mourning
- They Said, “Make It Your Home for Life” - Then Suddenly Kicked 200 Passengers Off... What Happened to the Around-the-World Cruise?
- "130 Rice Bowls Sold Out in a Day"... 'Unfiltered Face' Adds 8 Million Won to Night Market Sales: China's Bungeunwoo
Meanwhile, the Ministry of Health and Welfare recently established the payment rates and reimbursement criteria for manual therapy, which is subject to managed care reimbursement, through the Health Insurance Policy Review Committee. Starting in July, the fee for manual therapy will be set at 43,850 won per session (with a 95% patient co-payment), and the reimbursement limit is set at twice per week (up to 15 sessions per year). Prior to manual therapy, two weeks of basic physical therapy and simple rehabilitation must be performed, and in cases of surgery or fractures, up to 24 sessions per year will be recognized for reimbursement.
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.